#USA #Boston #Veeva #ACTO #LAICA™

ACTO Introduces a State-of-the-Art AI Assistant for Pharma Teams

At the recent Veeva Commercial Summit held in Boston, ACTO, a trusted technology partner of Veeva, announced the launch of LAICA™, the next-generation AI knowledge assistant specifically designed for pharmaceutical field teams. This innovative tool is set to redefine how sales representatives engage with healthcare professionals by delivering intelligent, tailored support in real-time.

Enhanced Personalization and Intelligence

The newly developed LAICA™ offers remarkable customization, allowing field teams to prepare more efficiently for their interactions. Parth Khanna, CEO of ACTO, highlighted that when LAICA was first launched three years ago, it initiated a transformative journey in the way field teams accessed and interacted with crucial knowledge. He noted, "AI continues to evolve, learning and adapting to deliver more precise, relevant, and personalized answers. The true magic occurs when AI assistants like LAICA connect with individuals in their current situation, intuitively understanding their needs and motivations."

LAICA™: Your Field Companion

Imagine a pharma representative, nervous before a meeting with an experienced healthcare provider. LAICA™ steps in, enabling the rep to ask last-minute questions right from the parking lot, ensuring they have the immediate answers needed for a confident presentation. This dynamic support enhances the representative’s abilities to communicate effectively, increasing their impact during critical interactions with healthcare professionals.

A Rich Knowledge Universe

The next iteration of LAICA™ will feature several connectors to pre-approved data sources, allowing for rapid and accurate responses to field inquiries. These integrations include:

• - Promotional and scientific content sourced through Veeva Vault PromoMats and MedComms
• - Real-time access to training materials, journal articles, and customer data
• - Information on market access, reimbursements, and prescribing data

This comprehensive "Knowledge Universe" enhances LAICA's cognitive abilities, enabling it to manage complex information and provide consistent, accurate responses. Alongside its knowledge capacity, LAICA’s emotional intelligence will develop further, customizing answers based on the user's training progress and confidence levels. This ensures that field professionals receive advice attuned to their expertise, empowering them to navigate discussions with healthcare providers effectively.

Lisa Dreher, National Sales Training Director at Currax Pharmaceuticals, emphasized the assistant’s importance: "Enabling our field teams to have impactful and personalized conversations with healthcare professionals is our ultimate goal. LAICA™ will help achieve this by providing quick, role-specific access to the insights they need, along with relevant suggestions that enhance pre-call planning and elevate the quality of their interactions."

Join Us at the Veeva Commercial Summit

Interested attendees will have the opportunity to experience LAICA™ firsthand at the ACTO booth during the Veeva Commercial Summit taking place from May 13-14, 2025. To stay updated on ACTO’s latest developments, visit www.acto.com or follow them on LinkedIn.

About ACTO

ACTO is an AI-driven Intelligent Field Excellence (IFE) platform tailored for the life sciences sector. It empowers teams in Sales, Marketing, and Medical Affairs to enhance client interactions and brand performance. With ACTO, biopharmaceutical companies can ensure their field professionals are always knowledgeable, confident, and credible, delivering the right message to healthcare professionals while providing senior leaders with insights to boost field team effectiveness. ACTO adheres to FDA 21 CFR Part 11 regulations and holds SOC 2 Type II certification, establishing itself as a trusted partner for intelligent field excellence in the life sciences industry.

© 2025 ACTO Technologies, Inc. All rights reserved. For media inquiries, contact Robert Minicucci at ACTO via email at [email protected] or call +1 339 206 1722.